Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 7/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13570450 | 0.98 | TSHR (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL6245920 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL9636052 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL7761655 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL162390 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| Hydrochloric Acid SCHEMBL11262444 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL7761593 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL11337153 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL9636042 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL28461971 | 0.98 | LMNA (0.62) | LMNATSHRHPGDHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1020 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025426-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2025-01-23 | — | — | US | claimed |
| CN-116999360-A | Anti-aging cosmetic and preparation method thereof | 上海普瑞康企业发展有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116437947-A | Non-pig formulations and methods thereof | 第一浪潮生物制药有限公司 | 2023-07-14 | — | — | CN | claimed |
| US-11478467-B2 | Targeted drug rescue with novel compositions, combinations, and methods thereof | Exciva GmbH (DE) | 2022-10-25 | — | — | US | claimed |
| US-20220296586-A1 | NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | Vepachedu, Sreenivasarao (US) | 2022-09-22 | — | — | US | claimed |
| US-20220218725-A1 | METHODS AND MATERIALS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2022-07-14 | — | — | US | claimed |
| EP-3968987-A1 | METHODS AND MATERIALS FOR TREATING CANCER | Mayo Foundation for Medical Education and Research (US) | 2022-03-23 | — | — | EP | claimed |
| US-20210330733-A1 | TOPICAL COMPOSITION FOR PAIN RELIEF | FULADI BOB (US) | 2021-10-28 | — | — | US | claimed |
| WO-2021086964-A1 | METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS | Precision Biologics (US) | 2021-05-06 | — | — | WO | claimed |
| WO-2020232439-A1 | METHODS AND MATERIALS FOR TREATING CANCER | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2020-11-19 | — | — | WO | claimed |
| EP-0169465-B1 | MIXTURE OF PYRIMIDO-PYRIMIDINES AND O-ACETYL-SALICYLIC ACID, OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, AND ITS USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-28 | — | — | EP | claimed |
| US-4880791-A | BLOOD DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-11-14 | — | — | US | claimed |
| US-4850489-A | Dispensing packs containing pharmaceutical combinations for sequential administration | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | claimed |
| EP-0292435-A1 | Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells | CIBA-GEIGY AG (CH) | 1988-11-23 | — | — | EP | claimed |
| US-4694024-A | ANTICOAGULANT MIXTURE | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-15 | — | — | US | claimed |
| EP-0089857-B1 | PHARMACEUTICAL COMPOUNDS AND PROCESS FOR THE MANUFACTURE OF SAME | R.P. SCHERER CORPORATION (US) | 1986-01-22 | — | — | EP | claimed |
| EP-0010061-B1 | PHARMACEUTICAL PREPARATIONS CONTAINING A MOLLUSC EXTRACT | Mc Farlane, Stuart John (NZ) | 1983-07-13 | — | — | EP | claimed |
| US-4340679-A | Culture media for inactivation of bacterial growth inhibitors | ABBOTT LABORATORIES (US) | 1982-07-20 | — | — | US | claimed |
| WO-1980000661-A1 | PHARMACEUTICAL PREPARATIONS | CROFT J (NZ) | 1980-04-17 | — | — | WO | claimed |
| US-4003999-A | MIXING ASPIRIN, TEA, AND A BASE TO FORM SOLUBLE ACETYL SALICYLATE; ACIDIFICATION | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-01-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11478467-B2 | Targeted drug rescue with novel compositions, combinations, and methods thereof | HTR2A, HTR2C, CYP3A43 | LMNA 1421/4885TSHR 1153/4885HPGD 517/4885 |
| US-20220218725-A1 | METHODS AND MATERIALS FOR TREATING CANCER | DDX21, LMNB1, XPOT | LMNA 178/4885TSHR 4386/4885HPGD 2330/4885 |
| US-20220296586-A1 | NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | CYP2D6, HTR2A, CYP3A43 | LMNA 2968/4885TSHR 1552/4885HPGD 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.